Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00836862 · ClinicalTrials.gov registry record
Arteriovenous Fistula Tissue Bank for Pre- and Post-Fistula Placement Specimens
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 43
- Enrollment target
NCT00836862: Completed study, sponsored by University of Nebraska.
NCT00836862 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00836862 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This project will bank sera, DNA and vascular specimens from patients undergoing arteriovenous fistula creation and revision.
Interventions
- OTHER Biologic specimens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2009-02-01 |
| Est. Completion | 2017-09-07 |
What the finished NCT00836862 record still lists
NCT00836862 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Biologic specimens is the first listed.
NCT00836862 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00836862 about?
NCT00836862 is a clinical study titled "Arteriovenous Fistula Tissue Bank for Pre- and Post-Fistula Placement Specimens". This project will bank sera, DNA and vascular specimens from patients undergoing arteriovenous fistula creation and revision.
What is the current status of trial NCT00836862?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2009-02-01. Estimated completion is 2017-09-07.
What interventions are being tested in trial NCT00836862?
The interventions under investigation include: Biologic specimens (OTHER).
Who is sponsoring clinical trial NCT00836862?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI